Apollo Endosurgery Acquires Allergan’s Obesity Intervention Division for $110M

Austin, Texas-based Apollo Endosurgery, a developer of medical devices and endoscopic surgical procedures, announced that it has entered into a definitive agreement to purchase the obesity intervention division of Allergan for up to $110 million.

Advertisement

Allergan’s obesity intervention division is responsible for manufacturing and marketing the FDA-approved LAP-BAND adjustable gastric band system and the ORBERA intra-gastric balloon system.

More Articles on Supply Chain:

Renovis Surgical’s Tesera Anterior Lumbar Interbody Fusion Cage Cleared by FDA
Dr. Jess Lonner Performs 100th Navio Robotic Partial Knee Replacement Surgery
Skyline Medical Announces 2nd Generation STREAMWAY Surgical Fluid Disposal

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.